Patents Assigned to HERPX LLC
  • Publication number: 20160143947
    Abstract: The present disclosure is directed to method of treating a herpes virus. In one embodiment, the method includes adding an effective amounts of stannous fluoride (SnF2) and antiviral synthetic nucleoside analog to a dosage form. The dosage form may be a scrim, a liquid (e.g., a nasal mist, an aerosol spray, a liquid eye drop, a liquid bandage, and the like), a mucoadhesive or a lip balm.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 26, 2016
    Applicant: HERPX LLC
    Inventors: Thomas Blake, Thomas F. Parigian, David E. Walsh
  • Publication number: 20130236521
    Abstract: The present disclosure is directed to method of treating a herpes virus. In one embodiment, the method includes adding an effective amount of stannous fluoride (SnF2) to a dosage form. The dosage form may be a scrim, a liquid (e.g., a nasal mist, an aerosol spray, a liquid eye drop, a liquid bandage, and the like), a mucoadhesive or a lip balm.
    Type: Application
    Filed: March 7, 2013
    Publication date: September 12, 2013
    Applicant: HERPX LLC
    Inventors: Thomas Blake, Thomas S. Parigian, David E. Walsh